Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Der Anaesthesist 48 (1999), S. 507-518 
    ISSN: 1432-055X
    Keywords: Schlüsselwörter Postoperatives Delir ; Postoperative psychiatrische Störungen ; Therapie ; Prophylaxe ; Key words Postoperative delirium ; Postoperative psychiatric disturbance ; Treatment ; Prophylaxis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract After surgical operations delirium can occur as a serious and possible lethal complication in about 5–15% of patients. Additionally, risk factors such as old age, polymedication, organic and psychiatric diseases raise the incidence. After open-heart- and orthopedic surgery more than half of the patients are affected. Delirium has negative effects on postoperative mobilization and reconvalescence and prolongs treatment on the ward. It is discussed in the literature that delirium may induce dementia in older patients. The correction of metabolic- and electrolyte imbalances, as well as the therapy of neurologic and psychiatric diseases, belongs to prophylactic treatment. Environmental conditions which facilitate reorientation of the patient after operation have beneficial effects. Some success has been achieved by using the nootropic substance piracetam as a prophylactic. In acute treatment, the butyrophenon-neuroleptic haloperidol is the drug of choice. In delirium caused by intoxication with anticholinergic agents, physostigmin is indicated. Benzodiazepines, clonidine and clomethiazole are used in particular for the treatment of withdrawal delirium.
    Notes: Zusammenfassung Nach operativen Eingriffen kommt es bei 5 bis 15% der Patienten zu einem Delir, welches eine ernste und potentiell tödliche Komplikation darstellt. Bei zusätzlich bestehenden Risikofaktoren wie hohem Alter, medikamentöser Mehrfachtherapie, somatischen und psychiatrischen Störungen findet sich eine noch wesentlich höhere Inzidenz. Bei Operationen am offenen Herzen und orthopädischen Eingriffen sind über die Hälfte der Patienten betroffen. Das Delir beeinträchtigt die postoperative Mobilisierung und Rekonvaleszenz der Patienten und führt zur Verlängerung des stationären Aufenthalts. Die Gefahr einer dementiellen Entwicklung als Spätfolge des Delir bei älteren Patienten wird in der Literatur diskutiert. Zu den Maßnahmen der Prophylaxe zählen die Behandlung von metabolischen Entgleisungen, Ausgleich von Elektrolytstörungen und Therapie von neurologischen und psychiatrischen Erkrankungen. Verhaltensmaßnahmen, die die Orientierung des Patienten nach der Operation erleichtern, haben eine günstige Wirkung. Erfolge wurden durch die prophylaktische Verabreichung des Nootropikums Piracetam berichtet. In der Akutbehandlung ist das Butyrophenon-Neuroleptikum Haloperidol Mittel der Wahl zur Sedierung. Bei Delirien auf der Grundlage einer Intoxikation mit anticholinerg wirkenden Pharmaka ist Physostigmin indiziert. Benzodiazepine, Clonidin und Clomethiazol kommen v.a. bei der Behandlung des Entzugsdelir zum Einsatz.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-2072
    Keywords: Schizophrenia ; negative symptoms ; clinical trials ; psychiatric status rating scales ; neuroleptics
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract There is little agreement about the methodology of clinical trials of antipsychotic drugs in patients with negative symptoms. A literature review revealed wide variation in experimental design, rating scales and study duration. This reflects differing views as to the definition and response to treatment of negative symptoms. Some degree of standardization would improve comparability of studies and aid the development of new compounds. Patients included in such studies should have displayed negative symptoms for at least 6 months. Depressive symptoms, positive schizophrenic symptoms and extrapyramidal signs may all influence or be confused with negative symptoms and may respond to treatment; they should be at a low level at baseline and should be measured during the study period. Studies should last at least 8 weeks. Several scales are available for measuring negative symptoms and are reviewed; a global impression score should be used additionally.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Springer
    European archives of psychiatry and clinical neuroscience 249 (1999), S. 144-149 
    ISSN: 1433-8491
    Keywords: Key words Depression ; Bipolar disorder ; Lithium ; Prophylaxis ; Efficacy
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract It has been reported recently that the prophylactic efficacy of lithium is a transient phenomenon in many patients. Other studies suggest sustained efficacy against affective recurrences for many years. As this issue is of major therapeutic relevance, published literature considering changes in lithium efficacy over time has been reviewed. The present review includes a critical evaluation of the data and the methodology which yielded these controversial results. Considering the published data discussed in this review, the balance of evidence does not indicate a general loss of lithium efficacy in the prophylaxis of major affective disorders. A supposed persistence of the prophylactic effects in general does not, however, exclude the reappearance of affective recurrences after years of successful treatment in individual cases. Possible reasons for this phenomenon are discussed.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    Journal of neural transmission 103 (1996), S. 217-245 
    ISSN: 1435-1463
    Keywords: Brofaromine ; reversible and selective inhibitors of monoamine oxidase (type A) ; pharmacology ; clinical trials
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary The antidepressant activity of monoamine oxidase inhibitors has been well established for 30 years. Nevertheless, this group of compounds was handled with great care, mainly because of the interaction potential with tyramine-containing foodstuff. With the discovery of reversible and selective inhibitors of monoamine oxidase type A a renaissance of these compounds has begun. In this paper one of these new substances — brofaromine — will be described in detail. Biochemical and pharmacological aspects will be reviewed, showing that brofaromine is a selective and reversible inhibitor of monoamine oxidase type A with additional serotonin reuptake inhibiting properties. Both mechanisms of action may synergize in the antidepressant effect of the compound. The main results of clinical trials in depression and other indication areas will also be covered. Special attention will be put on the side effect profile.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...